| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 05/07/2003 | EP1307237A2 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 05/07/2003 | EP1086079B1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids |
| 05/07/2003 | EP1029297B1 Method of virtual retrieval of analogs of lead compounds |
| 05/07/2003 | EP0986527B1 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst |
| 05/07/2003 | EP0981527B1 Salt of naphthyridine carboxylic acid derivative |
| 05/07/2003 | EP0940387B1 Phenylethanolamine compounds useful as beta3 agonist, process for producing the same, and intermediates in the production of the same |
| 05/07/2003 | CN1416416A Androgen receptor suppressors in treatment of hirsutism,acne and androgenetic alopecia |
| 05/07/2003 | CN1415619A Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage |
| 05/07/2003 | CN1415618A Compound possessing function for preventing and curing thrombus disease, its pharmacy compsn. and usage in medication |
| 05/07/2003 | CN1415617A Compound possessing function for preventing and curing atherosclerosis and its application in biologic pharmacological science |
| 05/06/2003 | US6559341 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides |
| 05/06/2003 | US6559312 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 05/06/2003 | US6559181 A method to treat endometrial carcinoma, prostate cancer, or prostate hyperplasia comprising administering to a patient in need of such treatment an effective dose of a 3,4-Diphenyl-bicyclo(4.3.0)nonyl compound of formula I |
| 05/06/2003 | US6559143 Class III electrophysiological activity, drugs which prolong the trans-membrane action potential duration and refractoriness, without affecting cardiac conduction |
| 05/06/2003 | US6559140 Cyclic and bicyclic diamino histamine-3 receptor antagonists |
| 05/06/2003 | US6559091 Metal complex ligated by a monodentate, bidentate, tridentate, or tetradentate ligand, wherein at least one of the donor atoms of the ligand is a nitrogen atom substituted by a 1-pyrrolyl or substituted 1- pyrrolyl group |
| 05/02/2003 | EP1306365A2 Cobalt supported catalysts for hydrogenation of nitriles |
| 05/02/2003 | EP1306083A1 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
| 05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 05/02/2003 | EP1305303A1 NOVEL FORM OF (R)- i N /i - 5-METHYL-8-(4-METHYLPIPERAZIN-1-YL)-1,2,3,4-TETRAHYDRO-2-NAPHTHYL]-4-MORPHOLINOBENZAMIDE |
| 05/02/2003 | EP0999840B1 Use of a draflazine analogue for treating pain |
| 05/02/2003 | EP0918761B1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 05/02/2003 | EP0831799B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders |
| 05/02/2003 | EP0811006B1 Benzopyran-containing compounds and method for their use |
| 05/01/2003 | WO2003035745A1 Blends of waxes and polymer additives |
| 05/01/2003 | WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 05/01/2003 | WO2003035602A1 Lipid modulators |
| 05/01/2003 | WO2003035599A1 Quarternary ammonium compounds and their use as antimuscarinic agents |
| 05/01/2003 | WO2003035057A1 Inhibitors of dipeptidyl peptidase iv |
| 05/01/2003 | WO2003035055A1 Mch antagonists for the treatment of obesity |
| 05/01/2003 | WO2003034989A2 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE |
| 05/01/2003 | WO2002098843A3 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors |
| 05/01/2003 | WO2002083842A3 Small molecule inhibitors of secretion of proteins encoded by are-mrnas |
| 05/01/2003 | WO2002044113A9 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 05/01/2003 | US20030083525 Reacting 1-naphthols with 2-(N-morpholiny)ethyl chloride forming 1-naphthol ethers which are reacted with hydroxyl-amine hydrochoride and acrylic acid forming 4-(2-((1)-naphthyloxy-(4)-acetamino)ethyl)morpholine |
| 05/01/2003 | US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives |
| 05/01/2003 | US20030083344 Tryptase inhibitors |
| 05/01/2003 | US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 05/01/2003 | US20030083335 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP) |
| 05/01/2003 | US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/01/2003 | US20030082403 Organic electroluminescent elements |
| 05/01/2003 | US20030080319 For use in bleaching and cleaning |
| 05/01/2003 | CA2464254A1 Inhibitors of post-proline cleaving proteases |
| 04/30/2003 | CN1414956A Substituted piperazine derivatives as MIP inhibitors |
| 04/30/2003 | CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof |
| 04/30/2003 | CN1413991A Method of fixed bed continuous synthetising piperazine series compound |
| 04/30/2003 | CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists |
| 04/30/2003 | CN1107060C Piperazingl cyclohexanols and compositions containing same and use thereof |
| 04/29/2003 | US6555709 Aromatic amides, their preparation process and their use as pesticides |
| 04/29/2003 | US6555689 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/29/2003 | US6555580 Treating arteriosclerosis and hypercholesterolaemia |
| 04/29/2003 | US6555541 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
| 04/29/2003 | US6555537 Piperazine derivatives and their use as anti-inflammatory agents |
| 04/29/2003 | US6554872 Cationic aminodianthraquinones, use, dyeing compositions containing them and methods of dyeing |
| 04/24/2003 | WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | US20030078428 Phenylamino benzhydroxamic acid derivatives inhibit certain dual specificity kinase enzymes involved in proliferative diseases such as cancer, psoriasis and restenosis; inhibit the phosphorylation of MAP kinase by MEK |
| 04/24/2003 | US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/24/2003 | US20030078302 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 04/24/2003 | US20030078250 Diphenyl urea compounds for treating a chemokine mediated disease; interleukin-8 (il-8) |
| 04/24/2003 | US20030078249 VLA-4 inhibitor compounds |
| 04/24/2003 | US20030078247 Enzyme inhibitor of a dipeptidyl peptidase for treating hyperglycaemia |
| 04/24/2003 | US20030078240 Reducing plaque formation, for the treatment of Alzheimer's disease |
| 04/24/2003 | CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/23/2003 | EP1304327A2 Glutamine-thiazolidide and -pyrrolidide and their use as dipeptidylpeptidase IV inhibitors |
| 04/23/2003 | EP1304322A2 Carboxylic acid compound and use thereof |
| 04/23/2003 | EP1303525A1 Production of novel phosphane ligands and use in catalytical reactions |
| 04/23/2003 | EP1303503A2 Aniline derivatives |
| 04/23/2003 | EP1303489A2 Alpha,alpha-dibromo-alpha-chloro-acetophenones as synthons |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2003 | EP1303477A2 1-amino-alkylcyclohexanes as 5-ht3- and neuronal nicotinicreceptor antagonists |
| 04/23/2003 | EP1303249A1 Antimycotic nail varnish composition |
| 04/23/2003 | EP1102739B1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 04/23/2003 | EP1082314B1 New dipeptidyl peptidase iv effectors |
| 04/23/2003 | EP1077975B1 Water soluble azoles as broad-spectrum antifungals |
| 04/23/2003 | EP1045690B1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use |
| 04/23/2003 | EP0993442B1 Hydrazine derivatives |
| 04/23/2003 | CN1413217A Olefin polymerization cocatalysts derived from group-15 compounds and process using them |
| 04/23/2003 | CN1413187A Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |
| 04/23/2003 | CN1413185A Substitued 1 and 2 naphthol mannich bases |
| 04/23/2003 | CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand |
| 04/23/2003 | CN1106461C Process for transporting cellulose solution in aqueous tertiary amine oxide and apparatus for producing cellulose moulded body by amine oxide process |
| 04/23/2003 | CN1106399C Process for preparing sildenafil |
| 04/23/2003 | CN1106391C Magnolol series compounds and synthesizing process thereof, and medicinal composition using same as active component |
| 04/22/2003 | US6552226 Tandem acyl-Claisen rearrangement in the preparation of chiral products |
| 04/22/2003 | US6552225 Such as n-(2,3-dichloro-4-(methylaminosulphonyl)phenyl)-3,3,3-trifluoro-2-hydroxy-2 -methylpropanamide; diabetes, obesity, lactic acidaemia |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552200 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/22/2003 | US6552088 Biphenyl derivatives |
| 04/22/2003 | US6552065 Antiproliferative agents |
| 04/22/2003 | US6552048 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals |
| 04/22/2003 | US6552047 H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use |
| 04/22/2003 | US6552023 Aralkyl substituted piperazine compounds |
| 04/22/2003 | US6552022 Atherosclerosis in a mammal, pancreatitis, non-insulin dependent diabetes mellitus, coronary heart disease in a lowering serum lipid levels |
| 04/17/2003 | WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 04/17/2003 | WO2003031408A2 Tricyclic compounds useful for modulating lxr |
| 04/17/2003 | WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/17/2003 | WO2003030889A1 Para-amino benzoic acids as integrin antagonists |